IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Biomarkers in Neuropsychiatry

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on September 3, 2024

Impact Score

2023-2024

1.37

h-Index

2023-2024

 11

Rank

2023-2024

 5463

SJR

2023-2024

 0.874

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Biomarkers in Neuropsychiatry
Abbreviation Biomark. Neuropsychiatry
Publication Type Journal
Subject Area, Categories, Scope Biochemistry (medical) (Q2); Clinical Biochemistry (Q2); Neurology (clinical) (Q2); Psychiatry and Mental Health (Q2)
h-index 11
Overall Rank/Ranking 5463
SCImago Journal Rank (SJR) 0.874
Impact Score 1.37
Publisher Elsevier B.V.
Country Netherlands
ISSN 26661446
Best Quartile Q2
Coverage History 2019-2023




About Biomarkers in Neuropsychiatry


Biomarkers in Neuropsychiatry is a journal covering the technologies/fields/categories related to Biochemistry (medical) (Q2); Clinical Biochemistry (Q2); Neurology (clinical) (Q2); Psychiatry and Mental Health (Q2). It is published by Elsevier B.V.. The overall rank of Biomarkers in Neuropsychiatry is 5463. According to SCImago Journal Rank (SJR), this journal is ranked 0.874. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 11. The best quartile for this journal is Q2.

The ISSN of Biomarkers in Neuropsychiatry journal is 26661446. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Biomarkers in Neuropsychiatry is cited by a total of 110 articles during the last 3 years (Preceding 2023).


Biomarkers in Neuropsychiatry Impact IF 2023-2024


The Impact IF 2023 of Biomarkers in Neuropsychiatry is 1.37, which is computed in 2024 as per its definition. Biomarkers in Neuropsychiatry IF is decreased by a factor of 1.04 and approximate percentage change is -43.15% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Biomarkers in Neuropsychiatry Impact IF 2024 Prediction


Impact IF 2023 of Biomarkers in Neuropsychiatry is 1.37. If the same downward trend persists, Impact IF may fall in 2024 as well.


Impact IF Trend


Year wise Impact IF of Biomarkers in Neuropsychiatry. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2023 1.37
2022 2.41
2021 3.75
2020 3.14
2019 0.00

Biomarkers in Neuropsychiatry h-index


  Table Setting

Biomarkers in Neuropsychiatry has an h-index of 11. It means 11 articles of this journal have more than 11 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Biomarkers in Neuropsychiatry ISSN


The ISSN of Biomarkers in Neuropsychiatry is 26661446. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Biomarkers in Neuropsychiatry Rank and SCImago Journal Rank (SJR)


The overall rank of Biomarkers in Neuropsychiatry is 5463. According to SCImago Journal Rank (SJR), this journal is ranked 0.874. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Biomarkers in Neuropsychiatry by Year


Year SJR
2023/2024 Coming Soon
2023 0.874
2022 0.954
2021
2020
2019

Ranking of Biomarkers in Neuropsychiatry by Year


Year Ranking
2023/2024 Coming Soon
2023 5463
2022 4538
2021 27030
2020 32841
2019 30415

Biomarkers in Neuropsychiatry Publisher


Table Setting

Biomarkers in Neuropsychiatry is published by Elsevier B.V.. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 2019-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Biomarkers in Neuropsychiatry is Biomark. Neuropsychiatry. This abbreviation ('Biomark. Neuropsychiatry') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Biomarkers in Neuropsychiatry


If your research field is/are related to Biochemistry (medical) (Q2); Clinical Biochemistry (Q2); Neurology (clinical) (Q2); Psychiatry and Mental Health (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Biomarkers in Neuropsychiatry?

Biomarkers in Neuropsychiatry latest impact IF is 1.37. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 3.75 (2021) and 0.00 (2019), respectively, in the last 5 years. Moreover, its average IS is 2.13 in the previous 5 years.


What's the SCImago Journal Rank (SJR) of the Biomarkers in Neuropsychiatry?

The Biomarkers in Neuropsychiatry has an SJR (SCImago Journal Rank) of 0.874, according to the latest data. It is computed in the year 2024. In the past 5 years, this journal has recorded a range of SJR, with the highest being 0.954 in 2022 and the lowest being in 2021. Furthermore, the average SJR of the Biomarkers in Neuropsychiatry over the previous 5-year period stands at 2.13.


What's the latest h-index of the Biomarkers in Neuropsychiatry?

The latest h-index of the Biomarkers in Neuropsychiatry is 11.


Who's the publisher of the Biomarkers in Neuropsychiatry?

The Biomarkers in Neuropsychiatry is published by the Elsevier B.V., with its country of publication being the Netherlands.


What's the current ranking of the Biomarkers in Neuropsychiatry?

The Biomarkers in Neuropsychiatry is currently ranked 5463 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 5 years, this journal has experienced varying rankings, reaching its highest position of 4538 in 2022 and its lowest position of 32841 in 2020.


What's the abbreviation or short name for the Biomarkers in Neuropsychiatry?

The standard ISO4 abbreviation for the Biomarkers in Neuropsychiatry is Biomark. Neuropsychiatry.


Is the "Biomarkers in Neuropsychiatry" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Biomarkers in Neuropsychiatry is classified as a journal that the Elsevier B.V. publishes.


What's the scope or major areas of the Biomarkers in Neuropsychiatry?

The Biomarkers in Neuropsychiatry encompasses the following areas:

  • Biochemistry (medical)
  • Clinical Biochemistry
  • Neurology (clinical)
  • Psychiatry and Mental Health

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Biomarkers in Neuropsychiatry?

The Biomarkers in Neuropsychiatry is assigned the following International Standard Serial Numbers (ISSN): 26661446.


What's the best quartile of the Biomarkers in Neuropsychiatry?

The best quartile for the Biomarkers in Neuropsychiatry is Q2 (2023).


What's the coverage history of the Biomarkers in Neuropsychiatry?

The Biomarkers in Neuropsychiatry coverage history can be summarized as follows: 2019-2023.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Current Sociology journal 7193 SAGE Publications Ltd 80 2.46
Journal of Competition Law and Economics journal 10133 Oxford University Press 30 0.96
Milan Journal of Mathematics journal 3538 Birkhauser Verlag Basel 29 1.14
Archives of the Balkan Medical Union journal 23592 Balkan Medical Union 12 0.21
Asian Textile Journal trade journal 27997 G P S Kwatra 11 0.03
Proceedings of the Royal Society of Queensland journal 21886 Royal Society of Queensland 12 0.00
Expert Review of Clinical Pharmacology journal 4520 Taylor and Francis Ltd. 60 3.53
Metascience journal 24313 Springer Nature 3 0.00
Journal of Digestive Diseases journal 6849 Wiley-Blackwell Publishing Ltd 62 1.99
East African journal of public health journal 19634 East African Public Health Association 23 0.00

Check complete list




Year wise Impact Score (IS) of Biomarkers in Neuropsychiatry

Impact Score Table

Year Impact Score (IS)
2024/2025 Coming Soon
2023 1.37
2022 2.41
2021 3.75
2020 3.14
2019 0.00



Top Journals/Conferences in Biochemistry (medical)

Chem
Elsevier Inc. | United States

Biomarker Research
BioMed Central Ltd | United Kingdom

Journal of Biomedical Science
BioMed Central Ltd | United Kingdom

Critical Reviews in Clinical Laboratory Sciences
Informa Healthcare | United Kingdom

MedComm
John Wiley and Sons Inc. | United States

Translational Research
Elsevier Inc. | United States

Journal of Clinical Endocrinology and Metabolism
Endocrine Society | United States

Clinical Chemistry
American Association for Clinical Chemistry Inc. | United States

Apoptosis : an international journal on programmed cell death
Springer Netherlands | Netherlands

EPMA Journal
BioMed Central Ltd | United Kingdom

See All

Top Journals/Conferences in Clinical Biochemistry

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Angiogenesis
Springer Netherlands | Netherlands

Biomarker Research
BioMed Central Ltd | United Kingdom

Redox Biology
Elsevier B.V. | Netherlands

Molecular Aspects of Medicine
Elsevier Ltd | United Kingdom

Journal of Biomedical Science
BioMed Central Ltd | United Kingdom

Cell Chemical Biology
Elsevier Inc. | United States

Critical Reviews in Clinical Laboratory Sciences
Informa Healthcare | United Kingdom

Journal of Clinical Endocrinology and Metabolism
Endocrine Society | United States

American Journal of Respiratory Cell and Molecular Biology
American Thoracic Society | United States

See All

Top Journals/Conferences in Neurology (clinical)

Lancet Neurology, The
Elsevier Ltd | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

JAMA Neurology
American Medical Association | United States

Molecular Neurodegeneration
BioMed Central Ltd | United Kingdom

Acta Neuropathologica
Springer Science and Business Media Deutschland GmbH | Germany

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Sleep Medicine Reviews
W.B. Saunders Ltd | United Kingdom

Translational Neurodegeneration
BioMed Central Ltd | United Kingdom

See All

Top Journals/Conferences in Psychiatry and Mental Health

World Psychiatry
Wiley-Blackwell | United States

Lancet Psychiatry,The
Elsevier Ltd | United Kingdom

Annual Review of Clinical Psychology
Annual Reviews Inc. | United States

JAMA Psychiatry
American Medical Association | United States

Clinical Psychology Review
Elsevier Inc. | United States

Psychotherapy and Psychosomatics
S. Karger AG | Switzerland

Lancet Healthy Longevity, The
Elsevier Ltd | United Kingdom

American Journal of Psychiatry
American Psychiatric Association | United States

Journal of the American Academy of Child and Adolescent Psychiatry
Elsevier Inc. | United States

Molecular Psychiatry
Springer Nature | United Kingdom

See All